Ads
related to: Treatment Macular Degeneration- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Appointment Tips
Get Tips And Useful Information
To Talk to your Retina Specialist
- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Wet AMD FAQs
Search results
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 6 days agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines
GuruFocus.com via Yahoo Finance· 2 days agoThe company also reported positive long-term data from its OpRegen treatment, showing sustained visual benefits, which underscores the therapys potential in treating geographic ...
STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION
WRBL Columbus· 5 days agoFood and Drug Administration ("FDA") has now determined that its New Drug Application ("NDA") for elamipretide for the treatment of Barth syndrome is entitled to a Priority ...
Indoor tanning beds and eyelash extensions: are they safe for teenagers? | Expert Opinion
Philly.com· 9 hours agoNow that the school year is ending soon and wardrobes are changing from puffy coats to prom dresses,...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results
Investing.com· 3 days agoThe therapy showed an average gain in visual acuity, contrasting with the typical loss experienced...
EyePoint reports mixed results in diabetic retinopathy trial By Investing.com
Investing.com· 6 days agoEyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) announced interim results from its Phase 2...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 3 days agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga via Yahoo Finance· 6 days agoOn Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2...
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks via Yahoo Finance· 5 days agoApellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga· 6 days agoThe data demonstrated that Duravyu has a biologic effect in patients with NPDR and a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint ...
Ads
related to: Treatment Macular Degeneration